Atlas Trials

A 14 Day Early Bactericidal Activity Study of Nitazoxanide for the Treatment of Tuberculosis

Clinical trial NCT02684240 · COMPLETED

Trial details

NCT number
NCT02684240
Sponsor
Weill Medical College of Cornell University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Tuberculosis
Start date
2016-02-01
Primary completion
2018-04-11
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.